BK Technologies insider sale; Suzuki retains 42,896 shares and 218,391 options

Rhea-AI Filing Summary

John M. Suzuki, CEO & President and a director of BK Technologies Corp (BKTI), reported a sale of company stock on 08/22/2025. He disposed of 3,000 shares of common stock at $70 per share, leaving him with 42,896 shares beneficially owned after the transaction. The filing also discloses a portfolio of outstanding stock options exercisable into 218,391 shares in aggregate across six option grants with exercise prices ranging from $11.65 to $42.81 and various vesting schedules, including time-based and performance-based vesting.

The Form 4 is a routine insider disclosure of ownership changes and option holdings; it documents the specific transaction, Suzuki’s roles with the issuer, and the vesting/expiration details provided for each option grant.

Insights

Financial Analyst

TL;DR: Insider sale of 3,000 shares at $70 is disclosed; material impact appears limited given remaining holdings and option exposure.

Mr. Suzuki reported a modest sale relative to his post-transaction holding of 42,896 shares. The Form 4 transparently lists vested and unvested option positions totaling 218,391 underlying shares with exercise prices from $11.65 to $42.81 and mixed vesting triggers, including performance conditions. From a capital-structure perspective, the disclosed option overhang is quantifiable and sizable in absolute terms, but the filing provides no company financials or indications of intent beyond the single sale. This is a routine disclosure useful for calculating potential dilution and short-term insider liquidity but contains no standalone financial performance data.

Corporate Governance Expert

TL;DR: Disclosure complies with Section 16 reporting; sale and option grants are documented with vesting details and signature.

The Form 4 clearly identifies the reporting person, his roles as CEO, President and director, and provides transaction date, type (sale), price and resulting beneficial ownership. The filing includes thorough explanatory notes on vesting conditions, including performance-based vesting and change-in-control provisions. For governance monitoring, this supports transparency around insider transactions and executive compensation structure; it raises no procedural concerns in the filing itself.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Suzuki John M

(Last) (First) (Middle)

C/O BK TECHNOLOGIES CORPORATION

7100 TECHNOLOGY DRIVE

(Street)

WEST MELBOURNE FL 32904

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BK Technologies Corp [ BKTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO & President

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		S		3,000	D	$70	42,896	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$15.4							07/19/2021(1)	07/19/2031	Common Stock	20,000		20,000	D
Stock Option (Right to Buy)	$11.65							03/01/2022(2)	03/01/2032	Common Stock	17,000		17,000	D
Stock Option (Right to Buy)	$12.4							(3)	06/22/2032	Common Stock	9,000		9,000	D
Stock Option (Right to Buy)	$15.53							07/11/2024(4)	07/11/2033	Common Stock	10,000		10,000	D
Stock Option (Right to Buy)	$12.27							02/06/2025(5)	02/06/2034	Common Stock	50,000		50,000	D
Stock Option (Right to Buy)	$42.81							07/10/2030(6)	07/09/2035	Common Stock	112,391		112,391	D

Explanation of Responses:

1. The option is fully vested.

2. The options were granted on March 1, 2022, and vest in five equal annual installments, beginning on March 1, 2022.

3. The options were granted on June 22, 2022, and will vest immediately upon a change in control that occurs on or before the five-year anniversary of the date of grant.

4. The options were granted on July 11, 2023, and vest in five equal annual installments, beginning on July 11, 2024.

5. The options were granted on February 6, 2024, and vest in five equal annual installments, beginning on February 6, 2025.

6. The option will vest and become exercisable upon achievement of certain performance-based stock price hurdles and continued employment with the issuer during the five-year performance period ending on July 10, 2030, subject to earlier vesting upon certain qualifying termination events.

	/s/ John M. Suzuki	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did John M. Suzuki (BKTI) report on 08/22/2025?

He reported a sale of 3,000 shares of BK Technologies common stock at a price of $70 per share on 08/22/2025.

How many BKTI shares does John M. Suzuki beneficially own after the reported transaction?

Following the sale, he beneficially owns 42,896 shares of common stock.

What stock option exposure does the Form 4 disclose for John M. Suzuki?

The filing lists option grants exercisable into a total of 218,391 common shares across six grants, with exercise prices from $11.65 to $42.81 and various vesting terms.

What roles does the reporting person hold at BK Technologies (BKTI)?

The form identifies John M. Suzuki as a Director, and as an Officer with the title CEO & President.

Are any of the disclosed options performance-based or subject to special vesting?

Yes. One option grant will vest upon achievement of performance-based stock price hurdles and continued employment over a five-year performance period; other grants include time-based and change-in-control vesting conditions as explained in the filing.